Acerca de

Boston, MA – October 27, 2025 – Anodyne Nanotech will present preclinical data on its Apelin RA patch, enabling muscle longevity and regeneration, at the upcoming Partnerships in Drug Delivery (PODD 2025) conference in Boston, MA.

 

Jake Lombardo, Co-founder & CEO, will present how Anodyne is enabling muscle regeneration with the Apelin RA patch, advancing a once-weekly GLP-1 patch to the clinic, and unlocking multi-molecule delivery through the company’s proprietary dry-formulation HeroPatch™ platform.

 

Konstantinos Tzortzakis, Co-founder & Chief Business Officer, will participate in the panel discussion “New Approaches for Expanding Transdermal Delivery Opportunities,” where he will highlight how Anodyne and its collaborators are overcoming the limits of transdermal delivery to create next-generation therapeutics.

 

The Anodyne team — Jake Lombardo, Konstantinos Tzortzakis, and Michael Elliott — will be available throughout the conference to meet with partners and discuss collaboration opportunities in transdermal biologic delivery.

 

We look forward to connecting in Boston on October 27–28.

To arrange a meeting, please contact us at partnering@theheropatch.com.